Implications of Differential Transcription Start Site Selection on CML and Prostate Cancer Cell Protein Expression

Scientists studied AGAP2 expression in prostate cancer and chronic myeloid leukemia, showing transcription was initiated from alternative transcription start sites (TSSs) within a single TSS cluster, producing cancer-type-specific AGAP2 mRNAs with small differences in their 5′ UTR length.